Related Experiment Video
Updated: Jun 3, 2026
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Gene expression analysis reveals novel altered genes in nasal polyps
Erica Babeto1, Marília De Freitas Calmon, Paola Jocelan Scarin Provazzi
1Laboratory of Genomics Studies, São Paulo State University - UNESP, São José do Rio Preto, SP, Brazil.
Molecular Medicine Reports
|April 8, 2011
Summary
Researchers identified four overexpressed genes (ATP2A1, SOLH, PLCD3, TGFβI) in nasal polyposis (NP) samples. These genes may play a role in the development of this chronic inflammatory nasal disease.
Area of Science:
- Genomics
- Molecular Biology
- Pathophysiology
Background:
- Nasal polyposis (NP) is a chronic inflammatory nasal mucosa disease affecting 4% of the population.
- The underlying pathophysiology of NP remains incompletely understood.
- Identifying novel genes is crucial for understanding NP development and potential therapeutic targets.
Purpose of the Study:
- To identify and characterize differentially expressed genes in nasal polyposis.
- To find potential biomarkers for NP prognosis and treatment.
- To elucidate the molecular mechanisms driving NP.
Main Methods:
- Real-time quantitative PCR was used to analyze gene expression in 11 NP samples and 13 normal nasal mucosa samples.
- Methylated CpG island amplification was employed for initial gene selection.
- Gene expression levels were compared between NP and normal tissues.
Main Results:
- Five differentially methylated clones were identified: ATP2A1, NOVA1, PLCD3, SOLH, and TGFβI.
- These genes exhibited methylated CpG islands between exons, not in promoter regions.
- Real-time PCR confirmed overexpression of ATP2A1, SOLH, PLCD3, and TGFβI in NP samples.
Conclusions:
- ATP2A1, SOLH, PLCD3, and TGFβI are overexpressed in nasal polyposis.
- These genes are likely involved in the formation and progression of nasal polyps.
- Further research into these genes may offer insights into NP pathogenesis and treatment.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...